BioElectronics Corp. (PKS. BIEL) have announced the details of their worldwide Direct Response Television (DRTV) strategy to enhance their international marketing efforts for their pain relieving ActiPatch and Allay brands. In December the company will launch their campaigns in Latin America, Canada in January, Europe and Australia in the first quarter and is currently working on the negotiations of a partnership to enter the Japanese market.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
The company has recently entered a contract with DRTV firm Schulberg MediaWorks for the production of several DRTV spots which are to be targeted at the English speaking world. The first of these spots can now be viewed over the company's website.
About BioElectronics Corporation
BioElectronics Corporation is the maker of ActiPatch Therapy, RecoveryRx(TM) Devices, HealFast(TM) Therapy (www.healfasttherapy.com) and the Allay(TM) family of inexpensive, disposable drug-free anti-inflammatory devices.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
